Entire-body PET Scans for Multiple Sclerosis

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

December 30, 2025

Conditions
Multiple Sclerosis
Interventions
DIAGNOSTIC_TEST

Entire-body PET-CT scans

Entire-body PET-CT scans will be performed with state-of-the-art scanners with different manufacturers' models including Siemens Biograph Vision, United Imaging uEXPLORER and possibly other recently FDA-approved PET-CT scanners.

DRUG

Amyvid radiopharmaceutical

Amyvid (F18-florbetapir) will be evaluated for binding to white matter of the peripheral and central nervous system of participants

Trial Locations (1)

92694

RECRUITING

Brain Health Alliance, Ladera Ranch

Sponsors
All Listed Sponsors
lead

Brain Health Alliance

OTHER

NCT04390009 - Entire-body PET Scans for Multiple Sclerosis | Biotech Hunter | Biotech Hunter